|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.6 CHF | -0.69% |
|
+0.28% | +40.67% |
| Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
| Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Cosmo Pharmaceuticals N.V. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 43.66 million compared to EUR 41.51 million a year ago. Net income was EUR 1.49 million compared to EUR 7.9 million a year ago.
Earnings per share was EUR 0.092 compared to EUR 0.476 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +40.67% | 1.26B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
COSMO PHARMACEUTICALS N.V. 
